Search Within

Gastrointestinal Oncology Service

Formats
  1. Journal Article (2351)
  2. Meeting Abstract (1873)
  3. Review (150)
  4. Book Section (127)
  5. Editorial (101)
  6. Guidelines (40)
  7. Correspondence (34)
  8. Conference Paper (24)
  9. Miscellaneous (23)
  10. Research Letter (17)
  11. Book Whole (12)
Groups
  1. Solid Tumor Oncology Division (4752)
  2. Department of Medicine (4750)
  3. Center for Pancreatic Cancer Research (2317)
  4. Surgery (1067)
  5. Survivorship Research (1014)
  6. Epidemiology and Biostatistics (844)

More Groups

People
  1. Eileen O'Reilly (805)
  2. Leonard Saltz (796)
  3. Ghassan Abou-Alfa (583)
  4. Nancy Kemeny (545)
  5. David Kelsen (538)
  6. David Ilson (443)

More People

Years
  1. 2025 (227)
  2. 2024 (309)
  3. 2023 (362)
  4. 2022 (346)
  5. 2021 (345)
  6. 2020 (326)

More Years

Publications
  1. Journal of Clinical Oncology (1290)
  2. Annals of Oncology (331)
  3. Annals of Surgical Oncology (148)
  4. Cancer (128)
  5. Clinical Cancer Research (107)
  6. Cancer Research (94)

More Publications

Publishers
  1. American Society of Clinical Oncology (1379)
  2. Oxford University Press (462)
  3. Elsevier Inc. (408)
  4. Springer (322)
  5. American Association for Cancer Research (282)
  6. Wiley Blackwell (243)

More Publishers

Results (4752)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Dose escalation stage of a first-in-class phase I study of the novel oral ERK 1/2 kinase inhibitor BVD-523 (ulixertinib) in patients with advanced solid tumors
    Meeting Abstract

    Infante, J. R.; Janku, F.; Tolcher, A. W.; Patel, M. R.; Sullivan, R. J.; Flaherty, K.; Carvajal, R. D.; Varghese, A. M.; Wong, D. J. L.; Sznol, M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Multicenter prospective phase II trial of bevacizumab (bev) for progressive pancreatic neuroendocrine tumor (PNET)
    Meeting Abstract

    Hobday, T. J.; Yin, J.; Pettinger, A.; Strosberg, J. R.; Reidy, D. L.; Chen, H. X.; Erlichman, C.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Identification of novel and potentially targetable receptor tyrosine kinase alterations in colorectal carcinoma using a 341 gene hybrid capture-based next-generation sequencing assay
    Meeting Abstract

    Hechtman, J. F.; Arcila, M. E.; Cheng, D. T.; Solit, D. B.; Yaeger, R. D.; Hyman, D. M.; Berger, M. F.; Shia, J.; Vakiani, E.; Zehir, A.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Hepatocellular carcinoma (HCC) and bone metastases (Mets)
    Meeting Abstract

    Harding, J. J.; Abu Zeinah, G.; Chou, J. F.; Owen, D. H.; Ly, M.; Lowery, M. A.; O'Reilly, E. M.; Capanu, M.; Saltz, L.; Abou-Alfa, G. K.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Safety and tolerability of increasing doses of CB-839, a first-in-class, orally administered small molecule inhibitor of glutaminase, in solid tumors
    Meeting Abstract

    Harding, J. J.; Telli, M. L.; Munster, P. N.; Le, M. H.; Molineaux, C.; Bennett, M. K.; Mittra, E.; Burris, H. A.; Clark, A. S.; Dunphy, M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • A phase I study of PF-05082566 (anti-4-1BB) + rituximab in patients with CD20+ NHL
    Meeting Abstract

    Gopal, A. K.; Bartlett, N. L.; Levy, R.; Houot, R.; Smith, S. D.; Segal, N. H.; Thall, A. D.; Mugundu, G.; Huang, B.; Davis, C.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase I trial of the HSP-90 inhibitor PU-H71
    Meeting Abstract

    Gerecitano, J. F.; Modi, S.; Rampal, R.; Drilon, A. E.; Fury, M. G.; Gounder, M. M.; Harding, J. J.; Hyman, D. M.; Varghese, A. M.; Voss, M. H.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • A randomized, double-blind, placebo-controlled phase III study of cisplatin plus a fluoropyrimidine with or without ramucirumab as first-line therapy in patients with metastatic gastric or gastroesophogeal junction (GEJ) adenocarcinoma (RAINFALL, NCT02314117)
    Meeting Abstract

    Fuchs, C. S.; Tabernero, J.; Al-Batran, S. E.; Chau, I.; Ilson, D. H.; Van Cutsem, E.; Ferry, D.; Emig, M.; Melemed, A. S.; Vanvoorden, V.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Steps in developing Watson for Oncology, a decision support system to assist physicians choosing first-line metastatic breast cancer (MBC) therapies: Improved performance with machine learning
    Meeting Abstract

    Fu, J.; Gucalp, A.; Zauderer, M. G.; Epstein, A. S.; Kris, M. G.; Keesing, J.; Caroline, A.; Megerian, M.; Eggebraaten, T.; DeLima, R.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • "Months, not years": Impact of clinical discussions of advanced cancer life-expectancy on patient illness understanding
    Meeting Abstract

    Epstein, A. S.; Prigerson, H. G.; Saltz, L.; O'Reilly, E. M.; Shah, M. A.; Maciejewski, P. K.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save